- Home
- NRP
NRP
Natural Resource Partners LP Limited Partnership
as 07-26-2024 4:00pm EST
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 26.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 13.43 | EPS Growth: | -1.18 |
| 52 Week Low/High: | $59.78 - $102.00 | Next Earning Date: | 08-06-2024 |
| Revenue: | $347,204,000 | Revenue Growth: | -12.86% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Natural Resource Partners LP Limited Partnership News
NRP Breaking Stock News: Dive into NRP Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Natural Resource Partners L.P. Schedules Second Quarter 2024 Earnings Conference Call
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
CNW Group
2 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Business Wire
2 months ago
Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
AFP
2 months ago
New Zealand scraps plan to tax livestock burps, farts
Business Wire
2 months ago
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
The Wall Street Journal
2 months ago
ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
Compare NRP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NRP Natural Resource Partners LP Limited Partnership - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.